Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
Gordon W. Moran, Allen Lim, Jennifer Bailey, et al.
Alimentary Pharmacology & Therapeutics (2013) Vol. 38, Iss. 9, pp. 1002-1024
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
Morten Lee Halling, Jens Kjeldsen, Torben Knudsen, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 33, pp. 6137-6146
Open Access | Times Cited: 200
Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel disease
Uday N. Shivaji, C Sharratt, Tom Thomas, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 49, Iss. 6, pp. 664-680
Open Access | Times Cited: 138
Cumulative Incidence of, Risk Factors for, and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience
E. Fréling, Cédric Baumann, Jean-François Cuny, et al.
The American Journal of Gastroenterology (2015) Vol. 110, Iss. 8, pp. 1186-1196
Closed Access | Times Cited: 119
European Crohn’s and Colitis Organisation Topical Review on IBD in the Elderly: Table 1.
Andreas Sturm, Christian Maaser, Michael Mendall, et al.
Journal of Crohn s and Colitis (2016), pp. jjw188-jjw188
Open Access | Times Cited: 117
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study
Daniela Pugliese, Luisa Guidi, Pietro Manuel Ferraro, et al.
Alimentary Pharmacology & Therapeutics (2015) Vol. 42, Iss. 7, pp. 880-888
Open Access | Times Cited: 107
Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population
Maryam M. Asgari, G. Thomas Ray, Jamie Geier, et al.
Journal of the American Academy of Dermatology (2017) Vol. 76, Iss. 4, pp. 632-638
Closed Access | Times Cited: 63
Psoriasis and Inflammatory Bowel Disease
Mario Cottone, C. Sapienza, Fabio Salvatore Macaluso, et al.
Digestive Diseases (2019) Vol. 37, Iss. 6, pp. 451-457
Open Access | Times Cited: 55
Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)
Kang‐Moon Lee, You Sun Kim, Geom Seog Seo, et al.
Intestinal Research (2015) Vol. 13, Iss. 3, pp. 193-193
Open Access | Times Cited: 64
Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases
Ripalta Colìa, Addolorata Corrado, Francesco Paolo Cantatore
Annals of Medicine (2016) Vol. 48, Iss. 8, pp. 577-585
Closed Access | Times Cited: 51
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Digestive and Liver Disease (2017) Vol. 49, Iss. 4, pp. 338-358
Open Access | Times Cited: 50
Long-term outcomes of pediatric inflammatory bowel disease
Soheila Nasiri, Mary Ellen Kuenzig, Eric I. Benchimol
Seminars in Pediatric Surgery (2017) Vol. 26, Iss. 6, pp. 398-404
Closed Access | Times Cited: 44
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris
Antonios G.A. Kolios, Nikhil Yawalkar, Mark Anliker, et al.
Dermatology (2016) Vol. 232, Iss. 4, pp. 385-406
Open Access | Times Cited: 39
Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease
Xianying Bao, Zemeng Feng, Jiming Yao, et al.
Mediators of Inflammation (2017) Vol. 2017, pp. 1-9
Open Access | Times Cited: 39
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort
Sébastien Godat, Nicolas Fournier, Ekaterina Safroneeva, et al.
European Journal of Gastroenterology & Hepatology (2018) Vol. 30, Iss. 6, pp. 612-620
Open Access | Times Cited: 37
Management of elderly ulcerative colitis in Japan
Masaaki Higashiyama, Akira Sugita, Kazutaka Koganei, et al.
Journal of Gastroenterology (2019) Vol. 54, Iss. 7, pp. 571-586
Open Access | Times Cited: 34
Cancer and Systemic Lupus Erythematosus
Alexandra Ladouceur, Basile Tessier‐Cloutier, Ann E. Clarke, et al.
Rheumatic Disease Clinics of North America (2020) Vol. 46, Iss. 3, pp. 533-550
Open Access | Times Cited: 32
Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy
Gaurav Nigam, Anirudh Bhandare, George Α. Antoniou, et al.
European Journal of Gastroenterology & Hepatology (2020) Vol. 33, Iss. 3, pp. 346-357
Closed Access | Times Cited: 24
Incidence of Skin Cancer in Patients With Chronic Inflammatory Cutaneous Diseases on Targeted Therapies: A Systematic Review and Meta-Analysis of Observational Studies
Salvatore Crisafulli, Lucrezia Bertino, Andrea Fontana, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels
Vivian Huang, Neil Dhami, Darryl K. Fedorak, et al.
Canadian Journal of Gastroenterology and Hepatology (2015) Vol. 29, Iss. 1, pp. 35-40
Open Access | Times Cited: 27
Systemic drug photosensitivity—Culprits, impact and investigation in 122 patients
Amirah Alrashidi, Lesley E. Rhodes, Jennifer Sharif, et al.
Photodermatology Photoimmunology & Photomedicine (2020) Vol. 36, Iss. 6, pp. 441-451
Open Access | Times Cited: 21
Disease-related and drug-induced skin manifestations in inflammatory bowel disease
Pieter Hindryckx, Gregor Novak, Antonio Costanzo, et al.
Expert Review of Gastroenterology & Hepatology (2017)
Closed Access | Times Cited: 22
Chemotherapeutic metabolism presenting as a recalcitrant case of hand–foot syndrome and mucositis
Kevin R. Kwan, Shayna R. Skokan, T. Blesh-Boren, et al.
Journal of Oncology Pharmacy Practice (2024) Vol. 30, Iss. 3, pp. 584-588
Closed Access | Times Cited: 2
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
Satohiro Matsumoto, Hirosato Mashima
Biologics (2018) Vol. Volume 12, pp. 69-73
Open Access | Times Cited: 20
Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis
Yang Song, Yanhong Shi, Chong He, et al.
World Journal of Gastroenterology (2015) Vol. 21, Iss. 19, pp. 6082-6087
Open Access | Times Cited: 20
Crohn’s disease and skin
Antonietta Gerarda Gravina, Alessandro Federico, Eleonora Ruocco, et al.
United European Gastroenterology Journal (2015) Vol. 4, Iss. 2, pp. 165-171
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top